BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland - ABC6 - Providence, RI and New Bedford, MA News, Weather

BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE BioHealth Innovation, Inc.

ROCKVILLE, Md., Feb. 27, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the formation of its Commercial Relevance Advisory Board (CRAB). Members of the CRAB represent diverse business and academic organizations from throughout the region, such as venture capital firm New Enterprise Associates, Ernst & Young, the Howard Hughes Medical Institute, the University of Maryland (UMD), Johns Hopkins University, and leading biotechnology companies.

The CRAB will assist BHI in evaluating market-relevant research and product development opportunities as well as help determine the commercial applicability of emerging entrepreneurs, companies and their science or technology. BHI will utilize feedback from CRAB members as part of its due diligence process for establishing formal client relationships and potentially future investments.

CRAB members include:

• Jesse  Baumgold, Principal, BioEnterprises, LLC
• Dan Bednarik, Senior Director, MEU Operations, Intrexon Corporation
• Judy Britz, Executive Director, Maryland Biotechnology Center
• Steve Canaras, Partner, Ernst & Young
• Edward Chan, NaviMed Capital
• Martha Connolly, Director, Maryland Industrial Partnerships (MIPS), UMD
• Tom Dann, Managing Director of Equity Funds, Maryland Venture Fund, Maryland State Department of Business & Economic Development
• Brian Darmody, Associate Vice President for Research and Economic Development, UMD
• Doug Doerfler, President & CEO, MaxCyte Inc.
• Moustapha El Amine, Senior Director, Scientific Services, Emergent BioSolutions
• Bill Enright, President & CEO, Vaxin Inc.
• Elizabeth Good, Director, Ventures, Johns Hopkins University
• Jim Hughes, Chief Enterprise and Economic Development Officer/Vice President at UMD Baltimore, & Director, UM Ventures
• Rachel King, CEO, GlycoMimetics, Inc.
• James Lee, Executive Vice President/CFO, Adventist Healthcare
• Raj Malik, Co-Founder & CEO, Infusd
• Ken Malone, Principal, Early Charm Ventures, LLC
• Arumani Manisundaram, Director, Center of Connected Health, Adventist Healthcare
• Chris Meenan, Director, Clinical Informatics, School of Medicine, UMD
• Arkesh Mehta, CEO, Chikujee Therapeutics
• Cheryl Moore, Executive Vice President & COO, Howard Hughes Medical Institute
• Sara Nayeem, Principal, New Enterprise Associates
• Jerry Parrott, Principal, Jerry Parrott LLC and Chair and President, Maryland Health Care Product Development Corporation
• Joana Rosario, Principal, J. Rosario et Al, LLC
• Rob Rosenbaum, President & Executive Director, TEDCO
• Vin Singh, CEO, Next Healthcare, Inc.
• Gayatri Varma, Executive Director, Office of Technology Commercialization, UMD

About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.

©2012 PR Newswire. All Rights Reserved.